Capricor Therapeutics Statistics

Total Valuation

FRA:4LN2 has a market cap or net worth of EUR 1.06 billion. The enterprise value is 984.54 million.

Market Cap	1.06B
Enterprise Value	984.54M

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	45.72M
Shares Outstanding	n/a
Shares Change (YoY)	+43.02%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	1.28%
Owned by Institutions (%)	31.93%
Float	40.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	111.40
PB Ratio	14.78
P/TBV Ratio	14.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-14.09
EV / Sales	102.90
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.89

Financial Position

The company has a current ratio of 3.59, with a Debt / Equity ratio of 0.17.

Current Ratio	3.59
Quick Ratio	3.50
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	-0.21
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -107.79% and return on invested capital (ROIC) is -64.37%.

Return on Equity (ROE)	-107.79%
Return on Assets (ROA)	-49.39%
Return on Invested Capital (ROIC)	-64.37%
Return on Capital Employed (ROCE)	-88.19%
Revenue Per Employee	59,291
Profits Per Employee	-436,749
Employee Count	160
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.56% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+21.56%
50-Day Moving Average	6.40
200-Day Moving Average	7.80
Relative Strength Index (RSI)	84.29
Average Volume (20 Days)	481

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.30

Income Statement

In the last 12 months, FRA:4LN2 had revenue of EUR 9.49 million and -69.88 million in losses. Loss per share was -1.54.

Revenue	9.49M
Gross Profit	-55.18M
Operating Income	-73.88M
Pretax Income	-69.88M
Net Income	-69.88M
EBITDA	-72.38M
EBIT	-73.88M
Loss Per Share	-1.54

Full Income Statement

Balance Sheet

The company has 84.01 million in cash and 12.39 million in debt, giving a net cash position of 71.61 million.

Cash & Cash Equivalents	84.01M
Total Debt	12.39M
Net Cash	71.61M
Net Cash Per Share	n/a
Equity (Book Value)	71.48M
Book Value Per Share	1.56
Working Capital	62.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -52.03 million and capital expenditures -6.25 million, giving a free cash flow of -58.28 million.

Operating Cash Flow	-52.03M
Capital Expenditures	-6.25M
Free Cash Flow	-58.28M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-778.80%
Pretax Margin	-736.62%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:4LN2 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.02%
Shareholder Yield	-43.02%
Earnings Yield	-6.61%
FCF Yield	-5.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 5, 2019. It was a reverse split with a ratio of 0.1.

Last Split Date	Jun 5, 2019
Split Type	Reverse
Split Ratio	0.1

Scores

FRA:4LN2 has an Altman Z-Score of 3.27 and a Piotroski F-Score of 1.

Altman Z-Score	3.27
Piotroski F-Score	1